Zhangzhou Pientzehuang Pharmaceutical. Ltd Financials

Market Capitalization CN¥120.14 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	39.99
Forward PE	33.02
Price to Sales TTM	CN¥11.17
Price to Book MRQ	CN¥7.87
Enterprise to Revenue	11.24
Enterprise to EBITDA	34.75

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	27.91%
Operating Margin	36.85%
Return on Assets TTM	11.65%
Return on Equity TTM	19.58%

Income Statement

Revenue TTM	CN¥10,758,701,056
Revenue per Share TTM	CN¥17.81
Quarterly Revenue Growth	-0.90%
Gross Profit TTM	CN¥4,515,740,160
EBITDA	CN¥3,603,383,892
Net Income to Common TTM	CN¥3,002,278,912
Diluted EPS TTM	CN¥4.98
Quarterly Earnings Growth YoY	2.60%

Balance Sheet

Total Cash MRQ	CN¥1,394,171,136
Total Cash per Share MRQ	CN¥2.31
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	6.84
Current Ratio MRQ	5.24
Book Value per Share MRQ	CN¥25.30

Cash Flow

Operating Cash Flow TTM	CN¥1,698,139,904
Levered Free Cash Flow TTM	CN¥3,707,175,680

600436 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	603,317,210
Float Shares	230,455,108
Avg 10 Volume	1,245,119
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	61.80%
% Held by Institutions	6.34%

Stock Price Summary

Beta	0.92
Fifty Two Week Low	CN¥189.90
Fifty Two Week High	CN¥284.34
Fifty Two Week Change	-0.60%
Day 50 MA	CN¥203.90
Day 200 MA	CN¥214.83

Dividends and Splits

Forward Annual Dividend Rate	CN¥4.60
Forward Annual Dividend Yield	2.32%
Trailing Annual Dividend Rate	CN¥1.15
Trailing Annual Dividend Yield	0.58%
Payout Ratio	69.82%
Dividend Date
Ex Dividend Date	2024-10-22
Last Split Factor
Last Split Date	2016-05-24